DRKS00013978已完成未知

Prospective, controlled trial on safety and efficacy of compression stockings for patients with CVI and pAVK (Angioflow2) - Angioflow 2

St. Josef und St. Elisabeth Hospital gGmbHKlinik für Dermatologie, Venerologie und Allergologie0 个研究点目标入组 55 人开始时间: 2018年2月9日最近更新: 2024年8月19日

研究概览

暂无简介。

•Age > 18 years old
•- Chronic venous insufficiency of any genesis (varicose disease, PTS, arthrogenic congestion syndrome, dependency syndrome in obesity) in stages C3 to C5.
•- ability to put on compression stockings or willingness to have them worn by third parties
•- Written consent form
•- Willingness to wear compression stockings of at least 8 hours per day during the study period
•- Peripheral arterial occlusive disease with an ankle arm index <0.9 and >0.5 and an absolute ankle arterial pressure >60mmHg

•- Pregnant or nursing patient
•- Patient participating in another treatment study Patients with severe general illness for whom there is a risk of withdrawal before the end of the study.
•- Patient with progressive malignant disease, associated with radiation therapy, Chemotherapy or hormone therapy treated.
•- allergy to components of the compression stocking
•- Absolute contraindication for an compression therapy: decompensated Heart failure, septic phlebitis, Phlegmasia coerulea dolens.
•- Acute deep or superficial leg vein thrombosis
•- disability or reluctance, put on compression stockings or to be worn florides Ulcus cruris, C6

发起方

St. Josef und St. Elisabeth Hospital gGmbHKlinik für Dermatologie, Venerologie und Allergologie